In unmatched samples (Figure 2A), CD300E was notably upregulated in cancers like BRCA, COAD, ESCA, GBM, HNSC, KIRC, and STAD, and downregulated in KICH, LIHC, LUAD, LUSC, and PAAD. Here, CD300E is linked to cancer.